STOCK TITAN

Director adds BLCO stake with 4,500-share buy and 4,500 RSUs grant

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Bausch & Lomb Corp director Ross Thomas W. Sr. reported two transactions in common shares. He made an open-market purchase of 4,500 common shares at a weighted average price of $17.679 per share, increasing his direct holdings to 64,891 shares immediately after the trade. In connection with this purchase, he also acquired 4,500 matching restricted share units (MRSUs) under the company’s matching share program, bringing his total reported direct holdings to 69,391 shares. One-third of these MRSUs will vest on each of the first, second, and third anniversaries of the grant date, subject to his continued service, with limited exceptions.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ross Thomas W. Sr.

(Last) (First) (Middle)
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT

(Street)
VAUGHAN A6 L4K 4B4

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 03/03/2026 P 4,500 A $17.679(1) 64,891 D
Common Shares, No Par Value 03/03/2026 A 4,500(2) A $0 69,391 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.672 to $17.690 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
2. Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).
/s/ Debra E. Levin, attorney-in-fact 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Bausch & Lomb (BLCO) report for Ross Thomas W. Sr.?

Bausch & Lomb reported that director Ross Thomas W. Sr. bought 4,500 common shares in an open-market purchase and received 4,500 matching restricted share units. These combined transactions increased his directly reported holdings to 69,391 common shares, including the new restricted share units.

How many Bausch & Lomb (BLCO) shares did the director buy and at what price?

Ross Thomas W. Sr. purchased 4,500 Bausch & Lomb common shares in the open market at a weighted average price of $17.679 per share. The filing notes the trades occurred in multiple transactions within a narrow range between $17.672 and $17.690 per share.

What are the matching restricted share units (MRSUs) granted to the BLCO director?

The director received 4,500 matching restricted share units (MRSUs) tied to his open-market share purchase under Bausch & Lomb’s matching share program. These units represent a form of equity compensation that converts into common shares as they vest over a defined schedule.

What is the vesting schedule for the Bausch & Lomb (BLCO) director’s MRSUs?

The 4,500 matching restricted share units granted to the director vest in three equal installments. One-third vests on each of the first, second, and third anniversaries of the grant date, subject to his continued service with limited specified exceptions in the agreement.

How did these transactions change the BLCO director’s reported share ownership?

After buying 4,500 shares, the director’s directly held common shares increased to 64,891. With the additional 4,500 matching restricted share units granted the same day, his total reported direct holdings, including the unvested units, rose to 69,391 according to the Form 4 disclosure.

Were the Bausch & Lomb (BLCO) director’s new shares acquired in the open market or as compensation?

The director acquired 4,500 common shares through an open-market purchase and 4,500 additional shares in the form of matching restricted share units. The open-market trade involved cash at a weighted average price, while the MRSUs were a non-cash equity award granted at zero stated price.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

6.24B
38.50M
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN